Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Hospital of the University of Pennsylvania

Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, United States is listed as a site for 710 registered clinical trials, 147 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 710
Ongoing 147

This page covers the site record Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the Hospital of the University of Pennsylvania report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 710 trials counted.

  • Phase 1 57 trials
  • Phase 1/2 28 trials
  • Phase 2 90 trials
  • Phase 2/3 11 trials
  • Phase 3 122 trials
  • Phase 4 24 trials
  • Not applicable 251 trials
  • Observational 115 trials
  • Expanded access 12 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 150 trials
  • Completed 415 trials
  • Terminated 118 trials
  • Other 27 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Expanded access)

Top of scale: 45

1996: 1 trials (Observational 1) 1998: 1 trials (Observational 1) 2001: 3 trials (Observational 1, Phase 2/3 1, Phase 2 1) 2002: 8 trials (Observational 2, Phase 3 3, Phase 2/3 1, Phase 2 1, Phase 1 1) 2003: 8 trials (Observational 1, Not applicable 5, Phase 4 1, Phase 1/2 1) 2004: 13 trials (Not applicable 3, Phase 4 1, Phase 3 5, Phase 2/3 1, Phase 2 3) 2005: 14 trials (Observational 2, Not applicable 3, Phase 4 2, Phase 3 4, Phase 2 2, Phase 1/2 1) 2006: 18 trials (Observational 6, Not applicable 4, Phase 4 1, Phase 3 4, Phase 2 1, Phase 1/2 1, Phase 1 1) 2007: 17 trials (Observational 1, Not applicable 3, Phase 4 1, Phase 3 7, Phase 2 3, Phase 1/2 1, Phase 1 1) 2008: 27 trials (Observational 4, Not applicable 7, Phase 4 1, Phase 3 6, Phase 2 6, Phase 1/2 1, Phase 1 2) 2009: 17 trials (Observational 2, Not applicable 4, Phase 4 1, Phase 3 4, Phase 2 4, Phase 1/2 1, Phase 1 1) 2010: 22 trials (Other 1, Observational 4, Not applicable 5, Phase 3 4, Phase 2 7, Phase 1 1) 2011: 20 trials (Observational 4, Not applicable 7, Phase 4 2, Phase 3 3, Phase 2 1, Phase 1 3) 2012: 36 trials (Other 1, Observational 6, Not applicable 13, Phase 4 1, Phase 3 8, Phase 2/3 1, Phase 2 1, Phase 1 5) 2013: 37 trials (Observational 12, Not applicable 10, Phase 3 5, Phase 2/3 1, Phase 2 2, Phase 1/2 2, Phase 1 5) 2014: 39 trials (Observational 4, Not applicable 23, Phase 4 1, Phase 3 3, Phase 2 3, Phase 1/2 1, Phase 1 4) 2015: 42 trials (Observational 7, Not applicable 14, Phase 4 1, Phase 3 9, Phase 2/3 1, Phase 2 5, Phase 1 5) 2016: 45 trials (Observational 5, Not applicable 15, Phase 4 2, Phase 3 7, Phase 2 10, Phase 1/2 4, Phase 1 2) 2017: 30 trials (Observational 2, Not applicable 9, Phase 3 6, Phase 2 11, Phase 1/2 2) 2018: 43 trials (Observational 8, Not applicable 14, Phase 4 1, Phase 3 9, Phase 2 6, Phase 1/2 2, Phase 1 3) 2019: 33 trials (Observational 6, Not applicable 13, Phase 4 2, Phase 3 4, Phase 2/3 1, Phase 2 3, Phase 1 4) 2020: 38 trials (Observational 9, Not applicable 10, Phase 4 2, Phase 3 8, Phase 2 3, Phase 1/2 1, Phase 1 5) 2021: 39 trials (Observational 8, Not applicable 14, Phase 4 2, Phase 3 6, Phase 2/3 1, Phase 2 5, Phase 1/2 2, Phase 1 1) 2022: 28 trials (Observational 4, Not applicable 12, Phase 4 1, Phase 3 2, Phase 2/3 1, Phase 2 3, Phase 1/2 1, Phase 1 4) 2023: 35 trials (Observational 3, Not applicable 18, Phase 3 2, Phase 2/3 1, Phase 2 3, Phase 1/2 4, Phase 1 4) 2024: 25 trials (Observational 4, Not applicable 15, Phase 3 2, Phase 2 1, Phase 1/2 2, Phase 1 1) 2025: 34 trials (Observational 6, Not applicable 18, Phase 3 5, Phase 2/3 1, Phase 2 2, Phase 1 2)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 22
2025 34
2024 25
2023 35
2022 28
2021 39
2020 38
2019 33
2018 43
2017 30

Showing 10 of 28 years.

Start your 14-day trial Email me all 28 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 3 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 710 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 208 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 401 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF